AndreaBozzo/ceres-open-data-index huggingface dataset:
Compound 530352: Tridecane, 7-ethyl-6-propyl

Chemical compound data from PubChem database. IUPAC Name: 7-ethyl-6-propyltridecane. Molecular Formula: C18H38. Molecular Weight: 254.5. This dataset contains comprehensive chemical information including structural data, physical properties, and biological activities. Useful for drug discovery, chemical research, and educational purposes.
National Survey of Substance Abuse Treatment Services (N-SSATS): 2008 Data on Substance Abuse Treatment Facilities

This report presents results from the 2008 National Survey of Substance Abuse Treatment Services (N-SSATS), an annual census of facilities providing substance abuse treatment. Conducted by the Substance Abuse and Mental Health Services Administration (SAMHSA), the N-SSATS is designed to collect data on the location, characteristics, and use of alcohol and drug abuse treatment facilities and services throughout the 50 states, the District of Columbia, and other U.S. jurisdictions.
Program Instruction (PI-19-02)

This Program Instruction (PI) provides guidance to states, territories, and insular areas (hereafter “states,” unless otherwise noted) on actions they are required to take to receive their allotments for Federal Fiscal Year (FY) 2020 (subject to the availability of appropriations) authorized under title IV-B, subparts 1 and 2, section 106 of CAPTA, Chafee and ETV programs.

PI-19-02 (PDF)

Fiscal Year 2018 Allotment Title IV-B Subpart 1 Stephanie Tubbs Jones Child Welfare Services
Fiscal Year 2018 Allotment Title IV-B Subpart 2 Promoting Safe and Stable Families
Fiscal Year 2018 Allotment for Title IV-B, Subpart 2 Monthly Caseworker Visit Funds
Fiscal Year 2018 Allotment for CAPTA
Fiscal Year 2018 Allotment for Chafee Foster Care Program for Successful Transition to Adulthood
Fiscal Year 2018 Allotment for Education and Training Vouchers

CFS-101 Instructions, Part I, II, and III

Introduction
Part I: Annual Budget Request for Title IV-B, Subpart 1 & 2 Funds, CAPTA, Chafee, and ETV Instructions
Part II: Annual Estimated Expenditure Summary of Child and Family Services Instructions
Part III: Expenditures for Title IV-B, Subparts 1 and 2, Chafee Foster Care Independence (Chafee) and Education and Training Voucher (ETV) Programs Instructions

CFS-101 Forms, Parts I, II and III Excel Workbook (XLSX) (40 KB)

CFS-101 Forms Part I
CFS-101 Forms Part II
CFS-101 Forms Part III

Assurances and Certifications

Title IV-B, subparts 1 and 2 (PDF  (PDF)- 86 KB)
CAPTA Assurance (PDF  (PDF)- 89 KB)
Chafee (PDF  (PDF)- 194 KB)
ETV (PDF  (PDF)- 80 KB)

CB Regional Program Managers

Notification of Adoption Savings Calculation Method

Annual Reporting of Education and Training Vouchers Awarded (PDF  (PDF)- 337 KB)

The PDF is best viewed in Chrome or Firefox. If using Internet Explorer (IE), please right click the link, save the file, and view it locally.

Metadata-only record linking to the original dataset. Open original dataset below.
Patent AT-E399818-T1: [Translated] BLOCK POLYMER COMPOSITION CONTAINING A METHACRYL RESIN

Provided in the present invention is an acrylic polymer composition comprising: (i) (a) a methacrylic resin and (b) a block copolymer having, in the molecule thereof, at least one structure in which (b2) polymer blocks each composed mainly of methacrylate ester units bonded to both ends of (b1) a polymer block composed mainly of acrylate ester units, and having a polymer block (b2) content of 10 to 50 wt% ; (ii) the weight ratio (a/b) of the methacrylic resin (a) to the block copolymer (b) falling within a range of 3/97 to 40/60; and (iii) the total amount of the methacrylic resin (a) and the polymer block (b2) component composed mainly of methacrylate ester units being 10 to 60 wt% based on the total amount of the resin components. The acrylic polymer composition according to the present invention can be used suitably as a molding or forming material for various purposes, because without impairing the excellent weather resistance and flexibility derived from acrylic thermoplastic elastomers, it possesses excellent balance between these properties and mechanical strength; and moreover, it is able to have improved transparency by heightening the affinity between the methacrylic resin (a) and block copolymer (b).
Growth ofHelicobacter pyloriin a long spiral form does not alter expression of immunodominant proteins

We have previously reported that altered culture conditions (a broth media with shaking) could induce a strain ofHelicobacter pylorito assume a long spiral morphology resembling that described forHelicobacter heilmannii. The present study was initiated to determine if other strains ofH. pyloricould be induced to assume that morphology and if doing so would alter the expression of immunodominant proteins.
Compound 528917: Thiophene, 3-(1-methylethyl)thio

Chemical compound data from PubChem database. IUPAC Name: 3-propan-2-ylsulfanylthiophene. Molecular Formula: C7H10S2. Molecular Weight: 158.3. This dataset contains comprehensive chemical information including structural data, physical properties, and biological activities. Useful for drug discovery, chemical research, and educational purposes.
Patent AT-E40146-T1: [Translated] IONICALLY MODIFIED PUR PAINTING PASTES AND THEIR USE.

The present invention is directed to the preparation of optionally pigmented spreading paste based on multiphase mixtures of ionically-modified polyurethanes and/or polyurethane ureas which are prepared from special synthesis components based on silicone resins, aromatic hydroxypolyethers, aromatichydroxy polyesters, and perfluorocarbon resins, the multiphase mixtures additionally containing water and organic solvents for the polyurethanes and/or polyurethane ureas. The present invention is also directed to the preparation of these optionally pigmented spreading pastes and to their use for the production of coatings permeable to water vapor on fabric or leather substrates by the direct or transfer method using the technique of evaporation.
Restaurant Inspections in Boulder County (2025-present)

Restaurant Inspection data for food service facilities within Boulder County, CO provided by Boulder County. To see new, up-to-date data, go to this link: https://data.colorado.gov/dataset/New-Restaurant-Inspections-in-Boulder-County/6ytb-f2cq/about_datahttps://data.colorado.gov/dataset/New-Restaurant-Inspections-in-Boulder-County/6ytb-f2cq/about_data
New York City – 5 Boros: Drug-Related Emergency Department Visits, 2004-2011 - Underage Drinking

Excel file with estimates, rates, relative standard errors, trends and confidence intervals for all drug-related emergency department (ED) visits involving underage drinking in New York City (5 boroughs), covering 2004-2011.  Underage drinking includes ED visits that involve alcohol use (alone or with other drugs) for patients under the age of 21.
Long term adaptation of a microbial population to a permanent metabolic constraint: overcoming thymineless death by experimental evolution of

Background
          To maintain populations of microbial cells under controlled conditions of growth and environment for an indefinite duration is a prerequisite for experimentally evolving natural isolates of wild-type species or recombinant strains. This goal is beyond the scope of current continuous culture apparatus because these devices positively select mutants that evade dilution, primarily through attachment to vessel surfaces, resulting in persistent sub-populations of uncontrollable size and growth rate.
        
        
          Results
          To overcome this drawback, a device with two growth chambers periodically undergoing transient phases of sterilization was designed. The robustness of this device was assessed by propagating an E. coli strain under permanent thymine starvation for over 880 days, i.e. metabolic conditions notoriously known to lead to cell death and clogging of cultivation vessels. Ten thousand generations were required to obtain a descendant lineage that could resist thymine starvation and had recovered wild-type growth rate.
        
        
          Conclusions
          This approach provides a technological framework for the diversification and improvement of microbial strains by long-term adaptation to inescapable metabolic constraints. An E. coli strain that is totally resistant to thymineless death was selected.
Patent AT-E399797-T1: [Translated] TUMOR-SPECIFIC RECOGNITION MOLECULES

Recognition molecules (RM), especially antibodies (A) that bind specifically to the Core-1 (C1) antigen, comprising defined amino acids sequences (1-6) given in the specification and below, are new. Recognition molecules (RM), especially antibodies (A) that bind specifically to the Core-1 (C1) antigen, comprising defined amino acids sequences (1-6): (a) AsnTyrTrpLeuGly (1); (b) AspIleTyrPro(Gly) 3TyrThrAsnTyrAsnGluLysPheLysGly (2); (c) AspIleTyrPro(Gly) 2SerTyrThrAsnTyrAsnGluLysPheLysGly (3); (d) TyrAspAlaAlaGlyProTrpPheAlaTyr (4); (e) TyrAspAlaAlaGlyProGlyPheAlaTyr (5); or (f) TyrAspAsnHisTyrPheAspTyr (6). Independent claims are also included for: (1) construct (B) consisting of (A) fused, chemically coupled or non-covalently associated with additional sequences and/or structures; (2) isolated nucleic acid (NA) containing sequences that encode at least one (A) or (B); (3) expression cassette or vector (X) comprising NA and functionally linked promoter; (4) virus or host cell that contains at least one (X); (5) organism that contains at least one host cell of (4); (6) method for preparing (A); and (7) kit containing (A) and/or (B). ACTIVITY : Cytostatic. A multibody (104; sequence of about 200 amino acids reproduced) was coupled to a chelating group then loaded with yttrium99. It was injected (dose 100 MicroCi) into the tail vein of a mouse, subcutaneously implanted with ZA-75-1 (Core-1 positive) tumor cells. A second dose was given after 3 weeks and this treatment produced a significant reduction in tumor growth (no figures given). MECHANISM OF ACTION : Neutralization of Core-1 antigen; Vaccine.
Patent AT-E400523-T1: [Translated] METHOD AND DEVICE FOR AUTOMATED PICKING AND PLACING OF COVER GLASSES

An apparatus and method for selecting and dispensing coverglasses over specimens on slides for the purpose of viewing specimens through a microscope. The selecting device contains a suctioning mechanism for picking up a coverglass from a stack of coverglasses. It also contains the ability to bend the coverglass to assist in separating the coverglasses. The apparatus further contains a matched barrier to eliminate any coverglasses that may stick to the selected coverglass. The selecting device also contains spring members which aid in the dispensing of the coverglass. After the suctioning mechanism releases the coverglass, the spring members exert a force onto the coverglass to insure that it is released from the selecting device and placed onto the slide. After placement of the coverglass onto the slide, capillary action pushes air bubbles out from underneath the coverglass.
Patent AT-E400772-T1: [Translated] VEHICLE HEADLIGHT AND LAMP

A vehicle headlight is described with a reflector housing ( 1, 21 ) and a front glass ( 22 ) which together enclose a headlight inner space. The headlight has a reference surface ( 15, 35 ) for defining the position of a lamp ( 7, 30 ) having a lamp body ( 8, 31 ) and a lamp base ( 9, 37 ) in the headlight The headlight is constructed such that the lamp ( 7, 30 ) can be inserted such that the lamp base ( 9, 37 ) is positioned in front of the lamp body ( 8, 31 ), viewed against the direction of radiation of the headlight In addition, a lamp ( 7, 30 ) is described which is constructed such that it can be inserted into the vehicle headlight in the manner described.
Managed Care Institutional Provider Network Data: December 31, 2014

The primary purpose for the Provider Network Data System is to collect data needed to evaluate the provider networks including physicians, hospitals, labs, home health agencies, durable medical equipment providers, etc., for all types of Managed Care plans in New York State, including HIV Special Need Plans (SNP), Family Health Plus (FHP) Buy-In, Programs of All-Inclusive Care for the Elderly (PACE), and Non-PACE Managed Long-Term Care (MLTC) plans. This dataset reflects institutional provider data. Provider Network Data System information is self reported. For more information, go to http://www.health.ny.gov/health_care/managed_care/.
Patent AT-E400965-T1: [Translated] MOBILE DEVICE AND METHOD OF OPERATION USING CONTEXT-SENSITIVE MENU KEYS IN A KEYBOARD LOCKING MODE

The present invention is a method and mobile terminal which permits at least one mobile terminal function to be activated and selected using at least one soft key during an inactive and locked mode of a mobile terminal keypad. A mobile terminal in accordance with the invention includes a controller (18); a keypad (2) comprising a plurality of keys (7, 8a, 8b, 10), including at least one soft key coupled to the controller, the keypad being under control of the controller and having an active mode during which key inputs from the keys activate mobile terminal functions and the inactive mode during which a first type of key input from the at least one soft key to the controller does not activate the mobile terminal functions; and wherein during the inactive mode, the controller is responsive to a second type of key input from at least one soft key which activates at least one mobile terminal function without return to the active mode.
Cysteine hydrochloride

ELCYS is an intravenous solution containing cysteine hydrochloride, an amino acid, used as a prescription medication. It comes in strengths like 50 mg/mL for injection, manufactured by Exela Pharma Sciences, LLC. Approved under NDA210660, it's administered intravenously for specific medical needs. This information was generated using AI and is provided for informational and research purposes only.
Patent AT-E400271-T1: [Translated] ARYL-PYRIDINE DERIVATIVES AS 11-BETA-HSD1 INHIBITORS

Chemical patent from PubChem database. Patent Number: AT-E400271-T1. Title: Bioactive Compound and Applications. Filing Date: 2011-12-19. Inventors: Yamamoto, Hiroshi, Schmidt, Hans. Abstract: A bioactive compound and its applications in pharmaceutical and agricultural fields are described. The compound exhibits significant biological activi... IPC Classifications: C07H, A61K, A61P. This patent covers 32 claims related to 4 chemical compounds. Useful for intellectual property research, prior art searches, and chemical innovation tracking.
COVID-19 State Profile Report - Mississippi

<b>After over two years of public reporting, the State Profile Report will no longer be produced and distributed after February 2023. The final release was on February 23, 2023. We want to thank everyone who contributed to the design, production, and review of this report and we hope that it provided insight into the data trends throughout the COVID-19 pandemic.
Data about COVID-19 will continue to be updated at <a href='https://covid.cdc.gov/covid-data-tracker/#datatracker-home' >CDC’s COVID Data Tracker</a>.
 </b>

<p>
The State Profile Report (SPR) is generated by the Data Strategy and Execution Workgroup in the Joint Coordination Cell, in collaboration with the White House. It is managed by an interagency team with representatives from multiple agencies and offices (including the United States Department of Health and Human Services (HHS), the Centers for Disease Control and Prevention, the HHS Assistant Secretary for Preparedness and Response, and the Indian Health Service). The SPR provides easily interpretable information on key indicators for each state, down to the county level.
 </p>

It is a weekly snapshot in time that:
<ul>
<li>Focuses on recent outcomes in the last seven days and changes relative to the month prior</li>
<li>Provides additional contextual information at the county level for each state, and includes national level information</li>
<li>Supports rapid visual interpretation of results with color thresholds</li>
</ul>
Compound 526908: 2-(3-Methylbutoxy)ethan-1-ol

Chemical compound data from PubChem database. IUPAC Name: 2-(3-methylbutoxy)ethanol. Molecular Formula: C7H16O2. Molecular Weight: 132.2. This dataset contains comprehensive chemical information including structural data, physical properties, and biological activities. Useful for drug discovery, chemical research, and educational purposes.
2022 National Substance Use and Mental Health Services Survey (N-SUMHSS) Detailed Tables

The Annual Detailed Tables present in-depth findings on location, characteristics, and utilization of substance use and mental health services as collected by the National Substance Use and Mental Health Survey (N-SUMHSS). The data presented are intended to provide behavioral health services providers; researchers; and federal, state, and local governments with information about the number and characteristics of public and private substance use and mental health treatment facilities nationwide.
Transcutaneous flow related variables measured in vivo: the effects of gender

Backgound
          The identification of potential sources of error is a crucial step for any new assessment technique. This is the case for transcutaneous variables, such as flow and arterial gases, which have been applied as functional indicators of various aspects of human health. Regarding gender, a particular subject-related determinant, it is often claimed that women present higher transcutaneous oxygen pressure (tcpO2) values than men. However, the statistical significance of this finding is still uncertain.
        
        
          Methods
          The haemodynamical-vascular response to a local reactive hyperaemia procedure (the tourniquet cuff manoeuvre) was studied in two previously selected group of volunteers (n = 16; 8 women and 8 men). The effect of gender was assessed under standardised experimental conditions, using the transcutaneous flow-related variables tcpO2-tcpCO2 and Laser-doppler Flowmetry (LDF).
        
        
          Results
          Regarding tcpO2, statistically significant differences between genders were not found, although higher values were consistently found for the gases in the female group. Regarding LDF, high statistically significant differences (p < 0.005) were found, with the men's group presenting the highest values and variability. Other derived parameters used to characterise the vascular response following the cuff-deflation (t-peak) were similar in both groups.
        
        
          Conclusions
          The relative influence of gender was not clearly demonstrated using these experimental conditions. However the gender-related LDF differences suggest that further investigation should be done on this issue. Perhaps in the presence of certain pathological disparities involving peripheral vascular regulation, other relationships may be found between these variables.
Patent AT-E400128-T1: [Translated] PERSONAL INFORMATION ENTRY SYSTEM, INFORMATION MANAGEMENT DEVICE AND METHOD FOR OBTAINING PERSONAL INFORMATION

The system has a set of game terminals (20, 22, 24), each with a unit for storing personal information input image information to allow a player to input personal information that is transmitted to an information management server (10). The server stores the information in another storing unit only when the information is correct or not is confirmed via the terminals image display. The information management server has an ID code setting unit that sets an ID code related to the stored personal information. An independent claim is also included for a method of obtaining personal information.
Patent AT-E400937-T1: [Translated] DEACTIVATION OF AT LEAST PARTIAL RECEIVER IN RESPONSE TO AT LEAST PARTIAL DETECTION OF THE EXISTENCE OF AN IDLE CONDITION

In one embodiment, a method is provided. In the method of this embodiment, in response, at least in part, to a determination that an idle condition exists, one or more packets may be transmitted to indicate, at least in part, that a transmitter is desired to refrain from transmitting, during one or more predetermined time intervals, to a receiver. Also in the method of this embodiment, also in response, at least in part, to the determination that the idle condition exists, the receiver may be de-activated, at least in part, during the one or more predetermined time intervals. Of course, many alternatives, variations, and modifications are possible without departing from this embodiment.
Patent AT-E400256-T1: [Translated] PHARMACEUTICAL COMPOSITION CONTAINING A CATIONIC EXCIPIENT

A pharmaceutical composition comprising a pharmaceutically effective amount of a pharmaceutically active substance and a pharmaceutically acceptable carrier including a cationic excipient, wherein said cationic excipient is a labile ester of betaine and a lipophilic alcohol having at least one primary hydroxyl group. Also, the use of a labile ester of betaine and a lipophilic alcohol having at least a primary hydroxyl group as a cationic excipient in a carrier for a pharmaceutical composition comprising a pharmaceutically active substance.
2013 CMHS Uniform Reporting System (URS) Tables for Idaho

Center for Mental Health Services (CMHS) Uniform Reporting System (URS) Tables for Idaho for 2013. The Uniform Reporting System (URS) is a state and national reporting system collected annually to support the Community Mental Health Services Block Grant program.  State Mental Health Authorities report on National Outcome Measures (NOMS), evidence based practices, and utilization measures providing an overview of state mental health delivery systems.
2012-2013 NSDUH National Maps of State Estimates

National maps presented here show estimates from the 2012-2013 National Surveys on Drug Use and Health (NSDUH) for 25 substance use and mental health outcomes, by age group, for 50 States and the District of Columbia. The color of each State indicates how a State ranks relative to other States for each measure.  States with the highest rates for a given measure are in red, with the exception of the perceptions of great risk measures, for which the lowest perceptions of great risk are in red. Those States with the lowest estimates are in white, with the exception of the perceptions of great risk measures, for which the highest perceptions of great risk are in white.
Patent AT-E401516-T1: [Translated] AUTOMATIC SHIFT CONTROL DEVICE FOR A MOTOR VEHICLE AND METHOD FOR DETERMINING THE SYNCHRONOUS POINT

A vehicle automatic shift operation controlling apparatus includes a synchronizer ring (32) having plural synchronizer ring teeth (320) arranged circumferentially at the synchronizer ring (32), and an opposing member (47) having plural opposing teeth (470) circumferentially at the opposing member (47), the plural opposing teeth (470) engageable with the plural synchronizer ring teeth (320) at a time of a change in a gear ratio in a transmission (2). The apparatus further includes a first processing unit (6m) configured to determine in actual practice a first balk point, which is one of the shift-up and shift-down side balk points, by implementing one of the shift-up and shift-down operations; and a second processing unit (6n) configured to anticipate, on a basis of the first balk point, a predicted value of a second balk point which is an other one of the shift-up and shift-down side balk points. <IMAGE>
National Mental Health Services Survey (N-MHSS): 2014, Data on Mental Health Treatment Facilities

This is an annual report that presents findings from the 2014 National Mental Health Services Survey (N-MHSS) conducted from April 2014 through January 2015. The N-MHSS collects information from all known facilities in the United States, both public and private, that provide mental health treatment services to people with mental illness. The N-MHSS is designed to collect data on the location, characteristics, and utilization of organized mental health treatment service providers throughout the 50 states, the District of Columbia, and the U.S. territories.